1. Home
  2. SCD vs ORGO Comparison

SCD vs ORGO Comparison

Compare SCD & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LMP Capital and Income Fund Inc.

SCD

LMP Capital and Income Fund Inc.

HOLD

Current Price

$15.45

Market Cap

356.2M

Sector

Finance

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.33

Market Cap

299.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCD
ORGO
Founded
2003
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
356.2M
299.8M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
SCD
ORGO
Price
$15.45
$2.33
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
45.5K
862.1K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
9.63%
N/A
EPS Growth
N/A
1600.00
EPS
N/A
N/A
Revenue
N/A
$564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$26.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.04
52 Week Low
$13.79
$2.04
52 Week High
$16.18
$7.08

Technical Indicators

Market Signals
Indicator
SCD
ORGO
Relative Strength Index (RSI) 54.88 43.41
Support Level $14.96 $2.24
Resistance Level $15.48 $2.67
Average True Range (ATR) 0.28 0.14
MACD -0.02 -0.01
Stochastic Oscillator 54.70 27.67

Price Performance

Historical Comparison
SCD
ORGO

About SCD LMP Capital and Income Fund Inc.

Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: